news

Oct 4 2017
Presentations at ID Week™ 2017 Highlight Clinical Results and Microbiome Analysis of Patients Treated in Rebiotix RBX2660 Phase 2 Studies

Oct 4 2017
KemPharm and Genco Sciences Announce Technology Licensing Agreement to Develop Prodrug-Based Therapy for Potential Rare Pediatric Indications of Tourette’s Syndrome with ADHD

Oct 3 2017
Ehave Highlights Solutions to Support and Improve ADHD Treatment During ADHD Awareness Month


 

events

Oct. 2-3 2017
Cowen Annual Therapeutics Conference

Oct. 17-18 2017
BIO Investor Forum

Nov. 1-2 2017
Life Sciences Summit

Nov. 1-2 2017
The 5th International mRNA Health Conference


 

spotlight